Jill Hazelwood
Lexicon Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Sphingolipid Metabolism and Signaling, Lipid Membrane Structure and Behavior, Carbohydrate Chemistry and Synthesis, Lysosomal Storage Disorders Research, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Inhibition of Sphingosine 1-Phosphate Lyase for the Treatment of Rheumatoid Arthritis: Discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime (LX2931) and (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)(2010)110 cited
- → Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders(2009)74 cited